You just read:

Ansun Biopharma Announces First Patient Enrolled In Phase 3 Clinical Trial Evaluating DAS181 In Hospitalized, Immunocompromised Patients With Lower Respiratory Tract Parainfluenza Virus Infection

News provided by

Ansun Biopharma, Inc.

May 28, 2019, 16:58 ET